Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

Intersubtype Human Immunodeficiency Virus Type 1 Superinfection Following Seroconversion to Primary Infection in Two Injection Drug Users

July 30, 2002

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!

This study describes two persons who are each infected with two different strains of HIV-1 (CRF01_AE and subtype B). The persons are injecting drug users participating in a prospective cohort study in Bangkok, Thailand. In both cases, the second infection (called "superinfection" as opposed to primary infection) was detected several weeks after the individuals had developed a strong antiviral response to the primary infection. Molecular and serologic analyses determined that the superinfecting strain belonged to a different subtype from the primary strain.

These data show that some individuals may not have the type or amount of immune response following primary HIV-1 infection to protect against a subsequent infection with a different HIV-1 strain. This finding has important implications for vaccine design, in that vaccines based on specific HIV-1 strains may not protect against all strains. Thus, HIV-1 vaccines will need to include elements from several HIV-1 subtypes to provide complete protection.

Back to other CDC news for July 30, 2002

Previous Updates

Adapted from:
Journal of Virology
08.02; Vol. 76; No. 15: P. 7444-7452; Artur Ramos; Dale J. Hu; Lily Nguyen; Kim-Oanh Phan; Suphak Vanichseni; Nattawan Promadej; Kachit Choopanya; Margaret Callahan; Nancy L. Young; Janet McNichol; Timothy D. Mastro; Thomas M. Folks; Shambavi Subbarao

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
More News and Research on HIV Superinfection (Reinfection)

Tools
 

Advertisement